PuSH - Publication Server of Helmholtz Zentrum München

Xiao, S.* ; Yosef, N.* ; Yang, J.* ; Wang, Y.* ; Zhou, L.* ; Zhu, C.* ; Wu, C.* ; Baloglu, E.* ; Schmidt, D.* ; Ramesh, R.* ; Lobera, M.* ; Sundrud, M.S.* ; Tsai, P.Y.* ; Xiang, Z.* ; Wang, J.* ; Xu, Y.* ; Lin, X.* ; Kretschmer, K.* ; Rahl, P.B.* ; Young, R.A.* ; Zhong, Z.* ; Hafler, D.A.* ; Regev, A.* ; Ghosh, S.* ; Marson, A.* ; Kuchroo, V.K.*

Small-molecule RORγt antagonists inhibit T helper 17 cell transcriptional network by divergent mechanisms.

Immunity 40, 477-489 (2014)
DOI Order publishers version
Open Access Green as soon as Postprint is submitted to ZB.
We identified three retinoid-related orphan receptor gamma t (RORγt)-specific inhibitors that suppress T helper 17 (Th17) cell responses, including Th17-cell-mediated autoimmune disease. We systemically characterized RORγt binding in the presence and absence of drugs with corresponding whole-genome transcriptome sequencing. RORγt acts as a direct activator of Th17 cell signature genes and a direct repressor of signature genes from other T cell lineages; its strongest transcriptional effects are on cis-regulatory sites containing the RORα binding motif. RORγt is central in a densely interconnected regulatory network that shapes the balance of T cell differentiation. Here, the three inhibitors modulated the RORγt-dependent transcriptional network to varying extents and through distinct mechanisms. Whereas one inhibitor displaced RORγt from its target loci, the other two inhibitors affected transcription predominantly without removing DNA binding. Our work illustrates the power of a system-scale analysis of transcriptional regulation to characterize potential therapeutic compounds that inhibit pathogenic Th17 cells and suppress autoimmunity.
Altmetric
Additional Metrics?
Edit extra informations Login
Publication type Article: Journal article
Document type Scientific Article
ISSN (print) / ISBN 1074-7613
e-ISSN 1097-4180
Journal Immunity
Quellenangaben Volume: 40, Issue: 4, Pages: 477-489 Article Number: , Supplement: ,
Publisher Cell Press
Publishing Place Cambridge, Mass.
Reviewing status Peer reviewed
Institute(s) Institute for Pancreatic Beta Cell Research (IPI)